CN Stock MarketDetailed Quotes

Jilin Aodong Pharmaceutical Group (000623)

Watchlist
  • 18.24
  • +0.47+2.64%
Market Closed Apr 10 15:00 CST
21.81BMarket Cap8.50P/E (TTM)

Jilin Aodong Pharmaceutical Group (000623) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Traditional Chinese medicine685.95M60.90%
连锁药店批发和零售186.89M16.59%
chemical143.4M12.73%
Food83.24M7.39%
Other products19.87M1.76%
Other operating income7.02M0.62%
View all

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
medicine829.36M73.63%
连锁药店批发和零售186.89M16.59%
Food83.24M7.39%
Other industries19.87M1.76%
Other operating income7.02M0.62%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Northeast China402.04M35.69%
East China260.57M23.13%
Southwest157.59M13.99%
South China139.51M12.39%
North China97.63M8.67%
Northwest69.04M6.13%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More